-
381
Development of novel nomograms for predicting prostate cancer in biopsy-naive patients with PSA < 10 ng/ml and PI-RADS ≤ 3 lesions
Published 2025-01-01Subjects: “…prostate cancer…”
Get full text
Article -
382
Cost-effectiveness Analysis of Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer Patients Without Previous Chemotherapy Treatment in Spain
Published 2018-01-01“…**Purpose:** To perform a cost-effectiveness analysis of radium-223 plus Best Supportive Care (BSC) compared to BSC in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and without previous docetaxel treatment in Spain. …”
Get full text
Article -
383
Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial.
Published 2021-01-01“…<h4>Conclusions</h4>OBT-fusion targeted FMA was feasible, precise, and safe in patients with low to intermediate risk localized prostate cancer.…”
Get full text
Article -
384
Stomach Metastasis in a Patient with Prostate Cancer 4 Years after the Initial Diagnosis: A Case Report and a Literature Review
Published 2012-01-01“…Prostate cancer commonly metastasizes bones and lymph nodes, but it very rarely spreads to the gastrointestinal tract. …”
Get full text
Article -
385
Case report of the first use of a hydrogel rectal spacer for prostate cancer reirradiation via LDR brachytherapy: applications and technical notes
Published 2025-01-01Subjects: Get full text
Article -
386
A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer
Published 2025-03-01“…Purpose: We report herein the 3-year results of a phase I/II prospective study of 4-fraction course of carbon-ion radiation therapy (CIRT) in patients with localized prostate cancer. Methods and Materials: The present was a single-institution, phase I/II prospective study including patients with low- or intermediate-risk prostate cancer, as defined by the National Comprehensive Cancer Network criteria. …”
Get full text
Article -
387
Defining national research priorities for prostate cancer in Zambia: using the Delphi process for comprehensive cancer policy setting in sub-Saharan Africa
Published 2024-07-01“…National priority research areas for prostate cancer in Zambia were identified as prostate cancer awareness; building affordable high-quality diagnostic capacity; affordability of specialist cancer treatments; supporting better access to medicines; delivery and coordination of services across the pathway and staff training.Conclusion The suggested seven priority areas allow for the development of the prostate cancer control programme to be conducted in a holistic manner. …”
Get full text
Article -
388
Novel hormonal agents in men with metastatic castration resistant prostate cancer and reduced performance status: Experiences of a specialized single center
Published 2024-12-01Subjects: “…castration‐resistant prostate cancer…”
Get full text
Article -
389
-
390
-
391
Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
Published 2025-01-01“…Previous studies suggest the possibility that dutasteride may be superior to finasteride in preventing prostate cancer. We directly compared the effects of finasteride and dutasteride on the risk of prostate cancer in patients with BPH using a pooled analysis of 15 real-world databases. …”
Article -
392
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Published 2025-01-01Subjects: Get full text
Article -
393
Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation
Published 2015-01-01“…One hundred and seven men (42–89 years) with prostate cancer undergoing androgen deprivation therapy completed a maximal graded objective exercise test to determine maximal oxygen uptake, assessments for resting metabolic rate, body composition, blood pressure and arterial stiffness, and blood biomarker analysis. …”
Get full text
Article -
394
-
395
Unsupervised self-organising map classification of Raman spectra from prostate cell lines uncovers substratified prostate cancer disease states
Published 2025-01-01“…Abstract Prostate cancer is a disease which poses an interesting clinical question: Should it be treated? …”
Get full text
Article -
396
Erratum to “Prostate Cancer in South Africa: Pathology Based National Cancer Registry Data (1986–2006) and Mortality Rates (1997–2009)”
Published 2014-01-01“…Prostate Cancer…”
Get full text
Article -
397
The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
Published 2025-01-01Subjects: “…prostate cancer…”
Get full text
Article -
398
Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
Published 2012-01-01“…Prostate Cancer…”
Get full text
Article -
399
Association between visceral adiposity index and prostate cancer in men aged 40 years and older: a nationwide cross-sectional study
Published 2025-12-01Subjects: Get full text
Article -
400
Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil
Published 2025-02-01“…PURPOSEWe investigated the impact of the funding source (public v private) on the overall survival (OS) of men with prostate cancer in Brazil.METHODSWe retrospectively analyzed patients with prostate cancer from a large hospital registry from the state of São Paulo, Brazil. …”
Get full text
Article